Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2019-09-19 Earnings Release
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
NanoRepro AG legt mit Portfolioerweiterung Grundstein fur weiteres Wachstum
Earnings Release Classification · 100% confidence The document is a news release dated September 19, 2019, detailing the financial performance for the '1. HJ 2019' (First Half Year 2019). It explicitly mentions key financial figures (Umsatz/Revenue of 790,000 Euro, EBITDA of -728,000 Euro) and discusses business developments, product launches, and outlook for the second half of the year. This structure—providing key financial highlights for a specific reporting period (H1) immediately following the period's end—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), but rather the initial announcement of the results. H1 2019
2019-09-19 German
Halbjahresabschluss 2019
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresabschluss' (Half-Year Financial Statement) for NanoRepro AG for the period ending June 30, 2019. It contains detailed balance sheets (Zwischenbilanz) and income statements (Zwischengewinn- und Verlustrechnung) comparing the current period to the previous year. Since it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2019
2019-09-19 German
NanoRepro: Umsatz im Gesamtjahr 2019 voraussichtlich unter Vorjahr
Earnings Release Classification · 100% confidence The document is a short announcement (2093 characters) dated September 9, 2019, classified as 'Ad-hoc' and 'Insiderinformationen' (Insider Information) under EU Regulation 596/2014. The core content is a revision of the full-year 2019 revenue forecast ('Umsatzerwartung für das Gesamtjahr 2019'). This is a preliminary announcement of financial expectations/changes, not the full detailed report (like 10-K or IR). It fits the definition of an Earnings Release (ER), which covers the initial announcement of periodical financial results/highlights, or a general Regulatory Filing (RNS). Since it specifically deals with revenue expectations and EBITDA guidance revision, 'ER' (Earnings Release) is the most precise fit among the financial categories, as it signals a change in expected performance before the final results are published. It is not a full report, thus ruling out 10-K or IR. FY 2019
2019-09-09 German
NanoRepro AG: 1. Quartal 2019 entwickelt sich planmaig
Earnings Release Classification · 100% confidence The document is a news release dated May 28, 2019, titled "NanoRepro AG: 1. Quartal 2019 entwickelt sich planmäßig" (NanoRepro AG: Q1 2019 developing as planned). It details key financial figures for the first quarter (Q1 2019), including revenue (€440,000) and EBITDA (-€293,400), discusses marketing investments, product launches, and provides an outlook for the full year 2019. This content structure—summarizing recent period results, providing commentary, and offering guidance—is characteristic of an Earnings Release (ER). It is not a comprehensive annual report (10-K) or a detailed interim report (IR), but rather the initial announcement of the results. Q1 2019
2019-05-28 German
NanoRepro AG bestatigt CEO Lisa Jungst
Board/Management Information Classification · 100% confidence The document is a short news release dated May 14, 2019, announcing the contract extension of the CEO, Lisa Jüngst, for three years. The text explicitly uses the header "Corporate News" and mentions "Schlagwort(e): Personalie" (Keyword: Personnel matter). This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management. The document is not a full financial report (10-K, IR) or a general regulatory filing (RNS), but a specific personnel announcement.
2019-05-14 German
Datum:30.04.2019
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) and 'Lagebericht' (Management Report) for NanoRepro AG for the fiscal year 2018. It contains detailed business model descriptions, product strategies, and regulatory frameworks. As it is a comprehensive annual report covering the full fiscal year, it falls under the 10-K category. FY 2018
2019-04-30 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.